Location Changed: Charles Sabine Lecture on Research Freedom, Huntington's Disease Sept. 27
The Fellows of the Graduate School and UC's CCTST welcome Emmy Award-winning journalist Charles Sabine for a special seminar at 5 p.m. Thursday, Sept. 27, in Kresge Auditorium of the Medical Sciences Building (MSB).
Sabine will discuss "The Pursuit of Hope and Dignity: Why Every Link in the Medical Chain Matters."
An international correspondent with NBC News for 26 years, in 2008 Sabine became a pioneering spokesman for freedom of scientific research and sufferers of degenerative brain illnesses--in particular, Huntingtons disease, which has ravaged his family.
In that role he has spoken at prestigious venues across the world, including the European and British parliaments, Royal Institution in London and World Congress for Freedom of Scientific Research. Sabine's father and brother both died of Huntington's, and genetic testing revealed that he too carries the gene for the disease.
Registration is not required. For more information, email laura.dickson@uc.edu
A free podcast of the presentation will be available at http://molgen.uc.edu on Oct. 3.
Tags
Related Stories
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.
Health care industry is hiring despite a job market that has cooled
April 16, 2026
The US labor market has cooled but the demand for health care workers, expecially skilled nurses, remains strong. Interviews with UC College of Nursing admininstrators Dr. Donna Green and Dr. Lindsay Davis were part of a WCPO segment on health care industry hiring.
AI advances in the liver disease field
April 15, 2026
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.